|
Hypertrophy
Citations 331-340 of 683 total displayed.
|
Past content
(since Mar 1999):
|
- Original Articles
Deletion of Angiotensin-Converting Enzyme 2 Accelerates Pressure Overload-Induced Cardiac Dysfunction by Increasing Local Angiotensin II
- Koichi Yamamoto, Mitsuru Ohishi, Tomohiro Katsuya, Norihisa Ito, Masashi Ikushima, Masaharu Kaibe, Yuji Tatara, Atsushi Shiota, Sumio Sugano, Satoshi Takeda, Hiromi Rakugi, and Toshio Ogihara
Hypertension 2006;47:718-726; published online before print as doi:10.1161/01.HYP.0000205833.89478.5b
[Abstract]
[Full text]
- Scientific Contributions
Association of Hemoglobin Delivery With Left Ventricular Structure and Function in Hypertensive Patients. Losartan Intervention For End Point Reduction in Hypertension Study
- Puneet Narayan, Vasilios Papademetriou, Kristian Wachtell, Eva Gerdts, Kurt Boman, Markku S. Nieminen, Giovanni de Simone, Björn Dahlöf, Frej Fyhrquist, Aud Hoieggen, and Richard B. Devereux
Hypertension published March 27, 2006, doi:10.1161/01.HYP.0000215578.40687.6f
[Abstract]
- Editorial Commentary
Compared With Whom? Addressing the Prognostic Value of Ambulatory Blood Pressure Categories
- Paolo Verdecchia, Fabio Angeli, and Jan A. Staessen
Hypertension published March 27, 2006, doi:10.1161/01.HYP.0000215364.56025.b9
[Abstract]
- Scientific Contributions
Vascular Endothelial Growth Factor Blockade Promotes the Transition From Compensatory Cardiac Hypertrophy to Failure in Response to Pressure Overload
- Yasuhiro Izumiya, Ichiro Shiojima, Kaori Sato, Douglas B. Sawyer, Wilson S. Colucci, and Kenneth Walsh
Hypertension published March 27, 2006, doi:10.1161/01.HYP.0000215207.54689.31
[Abstract]
- Editorial Commentaries
Growth Factor Receptor Transactivation in Mediating End Organ Damage by Angiotensin II
- Hiroyuki Suzuki and Satoru Eguchi
Hypertension 2006;47:339-340; published online before print as doi:10.1161/01.HYP.0000202497.83294.50
[Full text]
- Original Articles
Central Role for the Cardiotonic Steroid Marinobufagenin in the Pathogenesis of Experimental Uremic Cardiomyopathy
- David J. Kennedy, Sandeep Vetteth, Sankaridrug M. Periyasamy, Mohamed Kanj, Larisa Fedorova, Samer Khouri, M. Bashar Kahaleh, Zijian Xie, Deepak Malhotra, Nikolai I. Kolodkin, Edward G. Lakatta, Olga V. Fedorova, Alexei Y. Bagrov, and Joseph I. Shapiro
Hypertension 2006;47:488-495; published online before print as doi:10.1161/01.HYP.0000202594.82271.92
[Abstract]
[Full text]
- Corcoran Lecture
Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7): An Evolving Story in Cardiovascular Regulation
- Carlos M. Ferrario
Hypertension 2006;47:515-521; published online before print as doi:10.1161/01.HYP.0000196268.08909.fb
[Abstract]
[Full text]
- Part 2 Original Articles
Glucagon Receptor–Mediated Extracellular Signal–Regulated Kinase 1/2 Phosphorylation in Rat Mesangial Cells: Role of Protein Kinase A and Phospholipase C
- Xiao C. Li, Oscar A. Carretero, Yuan Shao, and Jia L. Zhuo
Hypertension 2006;47:580-585; published online before print as doi:10.1161/01.HYP.0000197946.81754.0a
[Abstract]
[Full text]
- Scientific Contributions
Targeted Deletion of Matrix Metalloproteinase 2 Ameliorates Myocardial Remodeling in Mice With Chronic Pressure Overload
- Hidenori Matsusaka, Tomomi Ide, Shouji Matsushima, Masaki Ikeuchi, Toru Kubota, Kenji Sunagawa, Shintaro Kinugawa, and Hiroyuki Tsutsui
Hypertension published February 27, 2006, doi:10.1161/01.HYP.0000208840.30778.00
[Abstract]
- Editorial Commentary
Matrix Reloaded. The Matrix Metalloproteinase Paradox
- Anna N. Panek and Michael Bader
Hypertension published February 27, 2006, doi:10.1161/01.HYP.0000208603.97395.44
[Abstract]
|
|
